Vice President and Physician-in-Chief, The University of Kansas Cancer Center
Douglas A. Girod, MD, Endowed Professor of Head and Neck Surgical Oncology, University of Kansas School of Medicine
Terance T. Tsue, MD, FACS, combines his expertise as professor, surgeon and researcher to provide clinical oversight at The University of Kansas Cancer Center as physician-in-chief. He is nationally recognized for his expertise in microvascular reconstructive surgery for head and neck cancers and, specifically, microvascular reconstruction of the jaw.
Dr. Tsue’s clinical focus is on tumors of the mouth, throat, voice box, neck and thyroid glands. Part of his focus concentrates on the latest techniques for the preservation of tissues and function, including conservation laryngeal surgery and the endoscopic removal of head and neck cancers using laser and robotic techniques. He also works closely with a multidisciplinary team to manage tumors of the skullbase, including the endoscopic removal of tumors and combined procedures involving neurosurgical approaches.
His writings on reconstructive microvascular surgery techniques and numerous ENT topics have been included in more than 90 publications and abstracts. He is often a featured presenter internationally at head and neck cancer symposiums. Since 2005, Dr. Tsue has been included in Best Doctors, a renowned electronic database and consulting service made up of the best 5% of physicians worldwide.
Dr. Tsue is a graduate of Johns Hopkins University School of Medicine and completed his residency at the University of Washington in Seattle. He has served on the faculty of the University of Kansas School of Medicine since 1996, rising to become the Douglas A. Girod, MD, Endowed Professor of Head and Neck Surgical Oncology and vice chairman, Department of Otolaryngology – Head and Neck Surgery in 2008. He served as associate dean for Graduate Medical Education and as the ACGME designated institutional official at the University of Kansas School of Medicine from 2008 to 2012. In 2012, he was appointed physician-in-chief of The University of Kansas Cancer Center, part of the University of Kansas Medical Center.